Peter Rice to Ceftriaxone
This is a "connection" page, showing publications Peter Rice has written about Ceftriaxone.
Connection Strength
0.834
-
Li S, Su XH, Le WJ, Jiang FX, Wang BX, Rice PA. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone. BMC Infect Dis. 2014 Nov 27; 14:622.
Score: 0.470
-
Li X, Le W, Lou X, Wang B, Genco CA, Rice PA, Su X. In Vitro Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae. Microbiol Spectr. 2021 10 31; 9(2):e0018121.
Score: 0.189
-
Su XH, Wang BX, Le WJ, Liu YR, Wan C, Li S, Alm RA, Mueller JP, Rice PA. Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). Antimicrob Agents Chemother. 2016 01; 60(1):621-3.
Score: 0.125
-
Li X, Le W, Lou X, Genco CA, Rice PA, Su X. In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019). Antimicrob Agents Chemother. 2022 05 17; 66(5):e0010922.
Score: 0.049